Commercial policy

Counterparts

JLE journals are transparent about their resources. All compensation that is given for the preparation of a manuscript and/or papers to be published in a journal is specified in the instructions to authors.

Supplements, thematic issues and special series

Supplements are collections of articles that address related issues or topics, are published as a separate issue of the journal or are an integral part of a regular issue, and are sometimes funded externally by the publisher. In order to prevent funding sources from influencing the content of supplements through the choice of topics and viewpoints expressed, JLE journals adopt the following principles, which also apply to externally funded and/or guest-edited supplement issues:

- The journal editor has full responsibility for the policies, practices, and content of the supplements, including full control over decisions regarding the selection of authors, expert reviewers, and supplement content. The funding agency is not permitted to influence the content of supplements;

- the editor of the journal has the right to appoint one or more outside editors to produce the supplement, and must assume responsibility for their work;

- The journal editor retains the authority to apply the external peer review process to manuscripts submitted for the supplement and to reject some of them, whether or not they have undergone such a process. These conditions are communicated to authors and external editors of supplements before editorial work begins;

- Where applicable, the origin of the supplement idea, the sources of funding for the research and publication of the supplement, and the products of the funding source in relation to the content of the supplement should be clearly stated in the introductory background information;

- Advertising in supplements must follow the same policies as the main journal;

- The editor of the journal should make it easy for readers to differentiate between the pages of the regular issue and the pages of the supplement;

- Journal editors and supplement editors receive no personal favors or direct compensation from supplement funders;

- secondary publication in supplements (republication of articles already published elsewhere) is clearly identified by the citation of the original article and the title ;

- The principles of authorship and declaration of interests, relationships and activities discussed elsewhere in this document also apply to supplements.

Sponsorship or partnership

Various entities may interact with the journals or editors in the form of sponsorship, partnerships, conferences, or other types of activities. To preserve editorial freedom, these interactions are managed according to the same principles described above for supplements.

Advertising

JLE magazines have formal and explicit written policies regarding advertising in both print and electronic versions as defined below.

JLE magazines do not contain advertisements promoting products proven to be harmful to health. JLE ensures that regulatory or industry standards on advertising specific to France are respected.

Readers are immediately able to distinguish between advertising and editorial content mentioned in the paper's masthead.

Advertisements for products making therapeutic claims but without a marketing authorization or CE mark (or local equivalent) must be submitted with all claims supported by full research articles published in peer-reviewed journals.

Sponsored content is clearly identifiable. The nature of any commercial relationship is transparent to our readers. Advertising and sponsorship must be delivered in context. Surreptitious or subliminal advertising is not permitted.

JLE does not allow advertising or sponsorship to influence editorial decisions.

Online advertising or sponsorship does not interfere with readers' access to editorial content.

Advertising and sponsorship of competitors is accepted.

JLE does not accept advertising or sponsorship related to tobacco products, or to the products and services of tobacco companies, their foundations or wholly owned subsidiaries.

Advertising and sponsorship are subject to editorial control.

The juxtaposition of editorial and advertising texts on the same products is prohibited.

Electronic publishing

Most medical journals today are published in both electronic and print formats, and some are available only in electronic format. The principles applicable to electronic and print publication are identical, and the recommendations provided in this document apply equally to both. However, electronic publishing offers the possibility of easily keeping track of successive versions of a file and raises concerns about the stability of links and preservation of content. These issues are covered below.

Permanent preservation of articles published on a journal's website or retention in an independent archive or trusted repository system is essential for historical purposes. Access to the archive may be unrestricted or restricted to subscribers to the system. However, if necessary for legal reasons (e.g., a libel suit), the URL of a removed article should contain a detailed explanation of the reasons for its removal and the article should be retained in the journal's internal archives.

The permanent preservation of the full content of a journal is the responsibility of JLE, which, in the event of the journal's closure, will ensure that the files are transferred to a responsible third party able to ensure their availability.

Journal websites publish the date of the last update of their general information pages, such as the list of their staff and editorial board members and their instructions to authors.